[SEOUL] South Korea's Kospi stock index edged higher on Friday on bargain hunting after losses in the previous session, though gains were limited by foreigners' sell-off. The Korean won held steady while the benchmark bond yield rose.South Korea's biggest drugmaker Celltrion and its affiliates, Celltrion HealthCare and Celltrion Pharm , jumped in expectation of improved profitability as the company begins to produce new biosimilar medication, Remsima SC.
In offshore trading, the won was quoted at 1,136.6 per U.S. dollar, unchanged from the previous day, while in one-year non-deliverable forward trading its one-month contract was quoted at 1,135.3 per dollar. The Kospi has risen 8.59 per cent so far this year, and gained 2.2 per cent in the previous 30 trading sessions.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
Sumber: BusinessTimes - 🏆 15. / 51 Baca lebih lajut »